| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
63,990,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Tenaya Therapeutics is a biotechnology company focused on discovering, designing, developing and delivering curative therapies that address the underlying drivers of heart disease. Co. is improving a pipeline of disease-modifying therapies developed using Co.'s product platforms and primary internal capabilities to target defined sub-populations of patients with prevalent forms of heart disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
4,444,444 |
4,444,444 |
4,444,444 |
27,429,319 |
| Total Buy Value |
$19,999,998 |
$19,999,998 |
$19,999,998 |
$79,713,241 |
| Total People Bought |
2 |
2 |
2 |
3 |
| Total Buy Transactions |
2 |
2 |
2 |
15 |
| Total Shares Sold |
32,609 |
32,609 |
59,437 |
59,437 |
| Total Sell Value |
$191,404 |
$191,404 |
$296,878 |
$296,878 |
| Total People Sold |
4 |
4 |
4 |
4 |
| Total Sell Transactions |
6 |
6 |
11 |
11 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hoey Timothy |
Chief Scientific Officer |
• – – |
2024-03-05 |
4 |
AS |
$7.00 |
$23,101 |
D/D |
(3,300) |
245,346 |
|
- |
|
| Ali Faraz |
Chief Executive Officer |
• • – |
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
198,079 |
|
- |
|
| Tingley Whittemore |
Chief Medical Officer |
• – – |
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
108,534 |
|
- |
|
| Hoey Timothy |
Chief Scientific Officer |
• – – |
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
248,646 |
|
- |
|
| Patterson Leone D |
Chief Fin. and Bus. Officer |
• – – |
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
95,755 |
|
- |
|
| Hoey Timothy |
Chief Scientific Officer |
• – – |
2024-02-20 |
4 |
AS |
$5.31 |
$35,046 |
D/D |
(6,569) |
236,146 |
|
- |
|
| Patterson Leone D |
Chief Fin. and Bus. Officer |
• – – |
2024-02-16 |
4 |
S |
$5.86 |
$30,478 |
D/D |
(5,201) |
60,755 |
|
- |
|
| Tingley Whittemore |
Chief Medical Officer |
• – – |
2024-02-16 |
4 |
S |
$5.86 |
$38,090 |
D/D |
(6,500) |
73,534 |
|
- |
|
| Hoey Timothy |
Chief Scientific Officer |
• – – |
2024-02-16 |
4 |
S |
$5.86 |
$27,431 |
D/D |
(4,681) |
242,715 |
|
- |
|
| Ali Faraz |
Chief Executive Officer |
• • – |
2024-02-16 |
4 |
S |
$5.86 |
$37,258 |
D/D |
(6,358) |
113,079 |
|
- |
|
| Tcg Opportunity Iii Gp, Llc |
|
– – • |
2024-02-12 |
4 |
B |
$4.50 |
$9,999,999 |
I/I |
2,222,222 |
13,599,275 |
0.01 |
- |
|
| Goeddel David V |
|
– • • |
2024-02-12 |
4 |
B |
$4.50 |
$9,999,999 |
I/I |
2,222,222 |
13,599,275 |
0.01 |
- |
|
| Hoey Timothy |
Chief Scientific Officer |
• – – |
2023-08-29 |
4 |
AS |
$4.26 |
$30,855 |
D/D |
(7,243) |
247,396 |
|
- |
|
| Ali Faraz |
Chief Executive Officer |
• • – |
2023-08-16 |
4 |
S |
$3.81 |
$21,195 |
D/D |
(5,563) |
119,437 |
|
- |
|
| Hoey Timothy |
Chief Scientific Officer |
• – – |
2023-08-16 |
4 |
S |
$3.81 |
$15,267 |
D/D |
(4,007) |
254,639 |
|
- |
|
| Tingley Whittemore |
Chief Medical Officer |
• – – |
2023-08-16 |
4 |
S |
$3.81 |
$21,195 |
D/D |
(5,563) |
76,437 |
|
- |
|
| Patterson Leone D |
Chief Fin. and Bus. Officer |
• – – |
2023-08-16 |
4 |
S |
$3.81 |
$16,962 |
D/D |
(4,452) |
64,542 |
|
- |
|
| Goeddel David V |
Director |
– • • |
2023-03-10 |
4 |
B |
$2.60 |
$17,596 |
I/I |
6,779 |
11,377,053 |
2.17 |
- |
|
| Tcg Opportunity Iii Gp, Llc |
10% Owner |
– – • |
2023-03-10 |
4 |
B |
$2.60 |
$17,596 |
I/I |
6,779 |
11,377,053 |
1.5 |
- |
|
| Ali Faraz |
Chief Executive Officer |
• • – |
2023-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
125,000 |
|
- |
|
| Patterson Leone D |
Chief Fin. and Bus. Officer |
• – – |
2023-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
67,000 |
|
- |
|
| Hoey Timothy |
Chief Scientific Officer |
• – – |
2023-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
258,646 |
|
- |
|
| Tingley Whittemore |
Chief Medical Officer |
• – – |
2023-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
80,000 |
|
- |
|
| Tcg Opportunity Iii Gp, Llc |
10% Owner |
– – • |
2023-02-08 |
4 |
B |
$2.60 |
$3,900,000 |
I/I |
1,500,000 |
11,370,274 |
1.5 |
- |
|
| Goeddel David V |
Director |
– • • |
2023-02-08 |
4 |
B |
$2.60 |
$3,900,000 |
I/I |
1,500,000 |
11,370,274 |
2.25 |
- |
|
42 Records found
|
|
Page 1 of 2 |
|
|
